Image
17.09.2020
Pharmacy campaign launches to support people with diabetes in Cambridg...
A six-week targeted campaign to empower people across the county living with diabetes to take control of ...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more